Quick Answer
Aldeyra Therapeutics, Inc. reported Common Stock Shares Outstanding of 60.16 million shares for the year ending 2025.
- Aldeyra Therapeutics, Inc. showed an increase of +0.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Aldeyra Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: 327,365 shares | Q3 2014: 5.57 million shares | Q1 2015: 6.89 million shares | Q2 2015: 9.71 million shares | Q3 2015: 9.71 million shares | Q1 2016: 9.71 million shares | Q2 2016: 12.47 million shares | Q3 2016: 12.57 million shares | Q1 2017: 15.13 million shares | Q2 2017: 15.15 million shares | Q3 2017: 19.12 million shares | Q1 2018: 19.66 million shares | Q2 2018: 20.84 million shares | Q3 2018: 20.99 million shares | Q1 2019: 26.91 million shares | Q2 2019: 26.99 million shares | Q3 2019: 27.15 million shares | Q1 2020: 29.51 million shares | Q2 2020: 33.00 million shares | Q3 2020: 38.63 million shares | Q1 2021: 38.67 million shares | Q2 2021: 38.67 million shares | Q3 2021: 38.67 million shares | Q1 2022: 58.30 million shares | Q2 2022: 58.30 million shares | Q3 2022: 58.56 million shares | Q1 2023: 58.79 million shares | Q2 2023: 58.80 million shares | Q3 2023: 59.19 million shares | Q1 2024: 59.41 million shares | Q2 2024: 59.41 million shares | Q3 2024: 59.55 million shares | Q1 2025: 60.05 million shares | Q2 2025: 60.05 million shares | Q3 2025: 60.16 million shares.
- Over the full 12 years of available data (2014 to 2025), Aldeyra Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 981.0%.
- Historical annual values: Fiscal year 2025: 60.16 million shares | Fiscal year 2024: 59.65 million shares | Fiscal year 2023: 59.20 million shares | Fiscal year 2022: 58.56 million shares | Fiscal year 2021: 58.08 million shares | Fiscal year 2020: 38.67 million shares | Fiscal year 2019: 28.66 million shares | Fiscal year 2018: 26.24 million shares | Fiscal year 2017: 19.14 million shares | Fiscal year 2016: 12.58 million shares | Fiscal year 2015: 9.71 million shares | Fiscal year 2014: 5.57 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: